| Revenue growth | ₹4,670.81 lakh (+89.59% YoY) in FY26. |
|---|---|
| Margins | EBITDA margin at 16.06% in FY26 vs 19.31% in FY25. |
| Demand visibility | Strong; 50k+ prescriptions per day and 10k+ doctors. |
| Management confidence | High; aiming for global footprint by 2030. |
Growth
FY26 Revenue reached ₹4,670.81 lakh (+89.59% YoY); EBITDA at ₹750.32 lakh (+57.73% YoY); PAT at ₹461.99 lakh (+49.05% YoY).
Outlook
Targets 500+ products in 3 years; pan-India expansion by 2029; launching new Mindcare and Orbit divisions.
Risks
Dependence on contract manufacturers; competitive pharmaceutical market; regulatory compliance across diverse geographies.
Earnings Call filed with BSE, BSE: 544529. Summary written with AI assistance from the document.
Aptus Pharma Ltd: key numbers
- Share price
- ₹385.20
- Market cap
- ₹660.6 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 143.0×Sector 47.4×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aptus Pharma Ltd
All →Aptus Pharma Annual General Meeting
Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.
Aptus Pharma Fund Raise of ₹44.88 Cr
Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.
- Value
- ₹44.88 Cr
- Execution
- 36 months
Aptus Pharma Annual Report
Aptus Pharma has filed its Annual Report for FY 2025-26 with the exchange. The report includes the notice for the upcoming 16th Annual General Meeting.
Aptus Pharma Annual General Meeting
Aptus Pharma Limited issued a notice for its 16th AGM on September 14, 2026, which includes a proposal for a preferential allotment of equity shares.
- Value
- ₹44.88 Cr
Aptus Pharma Capital Structure Change
Aptus Pharma approved a preferential issue of 16,02,870 equity shares at Rs. 280 per share, raising approximately Rs. 44.88 Crore. The board also scheduled the 16th AGM.
- Value
- ₹44.88 Cr
Aptus Pharma Board Meeting Outcome
Aptus Pharma Limited issued a clarification regarding typographical errors in its August 8, 2026, board meeting outcome. The correction specifies the meeting venue and annexure titles.